Global SCENESSE® demand drives increased CLINUVEL revenues, earnings 2023 Announcements . Financial . Regulatory 24.02.2023
Afamelanotide Significantly Reduces UV Skin Damage in a Healthy Population 2023 Announcements . Clinical . Regulatory 02.02.2023
Technical Note: Developing a melanocortin pipeline 2023 Announcements . Corporate . Regulatory 27.01.2023
Media release: CLINUVEL Trial Results Show Drug Reduces DNA Damage 2023 Announcements . Clinical . Regulatory 16.01.2023
Afamelanotide Reduces DNA Photodamage in Xeroderma Pigmentosum – Technical Note 2023 Announcements . Clinical . Regulatory 16.01.2023
Afamelanotide Reduces DNA Photodamage in Xeroderma Pigmentosum 2023 Announcements . Clinical . Regulatory 16.01.2023
Appendix 3Y – Change of Director’s Interest Notice 2022 Announcements . Financial . Regulatory 07.11.2022